GNRH1 and Familial prostate cancer: Androgen deprivation therapy (ADT), consisting of GnRH agonists (leuprolide acetate, goserelin and triptorelin) or GnRH antagonists (degarelix and relugolix), is the treatment foundational treatment for advanced prostate cancer.